PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA AMYLOID ANTIBODIES

Pharmaceutical compositions containing anti-beta amyloid (Aβ) antibodies or Aβ-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of Aβ in the central nervous system, mild cognitive impairment, and Aβ-associa...

Full description

Saved in:
Bibliographic Details
Main Authors ZUNIC Adnan, SULE Shantanu, GUPTA Kapil, LANTZ Steven Andrew
Format Patent
LanguageEnglish
Spanish
Published 28.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pharmaceutical compositions containing anti-beta amyloid (Aβ) antibodies or Aβ-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of Aβ in the central nervous system, mild cognitive impairment, and Aβ-associated disorders such as Alzheimer's disease. Se proporcionan composiciones farmacéuticas que contienen anticuerpos anti-beta amiloides (Aß) o fragmentos de unión a Aß de estos. Estas composiciones farmacéuticas son útiles en el tratamiento de la deposición o acumulación anormal de Aß en el sistema nervioso central, la deficiencia cognitiva leve y trastornos asociados a las Aß tales como la enfermedad de Alzheimer.
Bibliography:Application Number: MX20240010300